ES8604548A1 - Procedimiento para preparar nuevos derivados de acidos feni-laceticos - Google Patents

Procedimiento para preparar nuevos derivados de acidos feni-laceticos

Info

Publication number
ES8604548A1
ES8604548A1 ES545883A ES545883A ES8604548A1 ES 8604548 A1 ES8604548 A1 ES 8604548A1 ES 545883 A ES545883 A ES 545883A ES 545883 A ES545883 A ES 545883A ES 8604548 A1 ES8604548 A1 ES 8604548A1
Authority
ES
Spain
Prior art keywords
group
general formula
methyl
compound
piperidino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES545883A
Other languages
English (en)
Other versions
ES545883A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of ES545883A0 publication Critical patent/ES545883A0/es
Publication of ES8604548A1 publication Critical patent/ES8604548A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Lubricants (AREA)
  • Glass Compositions (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE ACIDOS FENILACETICOS, DE FORMULA GENERAL (I), EN LA QUE R1 SIGNIFICA UN GRUPO ALQUILENIMINO CON 4 A 6 ATOMOS DE CARBONO, NO RAMIFICADO; R2 SIGNIFICA UN ATOMO DE HIDROGENO O HALOGENO; R3 SIGNIFICA UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO DE 1 A 7 ATOMOS DE CARBONO; R4 SIGNIFICA UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO DE 1 A 3 ATOMOS DE CARBONO; Y W SIGNIFICA UN GRUPO METILO O FORMILO, Y SUS SALES FARMACEUTICAMENTE ACEPTABLES. CONSISTE EN REDUCIR UN COMPUESTO DE FORMULA GENERAL (II), EN LA QUE R1, R2, R4 Y W TIENEN LOS SIGNIFICADOS YA MENCIONADOS; E Y SIGNIFICA UN GRUPO DE FORMULA (III). DE APLICACION EN EL TRATAMIENTO DE LA DIABETES MELLITUS.
ES545883A 1983-12-30 1985-08-05 Procedimiento para preparar nuevos derivados de acidos feni-laceticos Expired ES8604548A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833347565 DE3347565A1 (de) 1983-12-30 1983-12-30 Neue phenylessigsaeurederivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE19853522604 DE3522604A1 (de) 1983-12-30 1985-06-25 Neue feste formen von 2-(gamma)thoxy-4-(n-(1-(2-piperidino-phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl)-benzoesaeure, diese formen enthaltende arzneimittel und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ES545883A0 ES545883A0 (es) 1986-02-01
ES8604548A1 true ES8604548A1 (es) 1986-02-01

Family

ID=37847099

Family Applications (7)

Application Number Title Priority Date Filing Date
ES539078A Expired ES8605500A1 (es) 1983-12-30 1984-12-27 Procedimiento para preparar derivados de acidos fenilaceticos.
ES545881A Expired ES8604546A1 (es) 1983-12-30 1985-08-05 Procedimiento para preparar nuevos derivados de acidos feni-laceticos
ES545879A Expired ES8604544A1 (es) 1983-12-30 1985-08-05 Procedimiento para preparar nuevos derivados de acidos feni-laceticos
ES545880A Expired ES8604545A1 (es) 1983-12-30 1985-08-05 Procedimiento para preparar nuevos derivados de acidos feni-laceticos
ES545882A Expired ES8604547A1 (es) 1983-12-30 1985-08-05 Procedimiento para preparar nuevos derivados de acidos feni-laceticos
ES545883A Expired ES8604548A1 (es) 1983-12-30 1985-08-05 Procedimiento para preparar nuevos derivados de acidos feni-laceticos
ES556495A Expired ES8802145A1 (es) 1983-12-30 1986-06-24 Procedimiento para preparar dos nuevas formas solidas de acido 2-etoxi-4-(n-(1-(2-piperidino-fenil)-3-metil-1-butil)-aminocarbonilmetil)-benzoico

Family Applications Before (5)

Application Number Title Priority Date Filing Date
ES539078A Expired ES8605500A1 (es) 1983-12-30 1984-12-27 Procedimiento para preparar derivados de acidos fenilaceticos.
ES545881A Expired ES8604546A1 (es) 1983-12-30 1985-08-05 Procedimiento para preparar nuevos derivados de acidos feni-laceticos
ES545879A Expired ES8604544A1 (es) 1983-12-30 1985-08-05 Procedimiento para preparar nuevos derivados de acidos feni-laceticos
ES545880A Expired ES8604545A1 (es) 1983-12-30 1985-08-05 Procedimiento para preparar nuevos derivados de acidos feni-laceticos
ES545882A Expired ES8604547A1 (es) 1983-12-30 1985-08-05 Procedimiento para preparar nuevos derivados de acidos feni-laceticos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES556495A Expired ES8802145A1 (es) 1983-12-30 1986-06-24 Procedimiento para preparar dos nuevas formas solidas de acido 2-etoxi-4-(n-(1-(2-piperidino-fenil)-3-metil-1-butil)-aminocarbonilmetil)-benzoico

Country Status (26)

Country Link
EP (2) EP0147850B1 (es)
JP (2) JPH0623200B2 (es)
KR (1) KR900005320B1 (es)
AT (1) ATE44027T1 (es)
AU (2) AU577815B2 (es)
BG (1) BG61519B2 (es)
CA (2) CA1225398A (es)
CS (1) CS409791A3 (es)
DD (1) DD231348A5 (es)
DE (4) DE3347565A1 (es)
DK (2) DK167439B1 (es)
ES (7) ES8605500A1 (es)
FI (2) FI80447C (es)
GR (2) GR82614B (es)
HK (1) HK87492A (es)
HU (1) HU194548B (es)
IE (1) IE57700B1 (es)
IL (2) IL73963A (es)
LU (1) LU90301I2 (es)
MX (1) MX9202772A (es)
NL (1) NL980034I1 (es)
NO (3) NO162819C (es)
NZ (2) NZ210657A (es)
PT (2) PT79772B (es)
SG (1) SG55492G (es)
ZA (2) ZA8410103B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3523466A1 (de) * 1985-07-01 1987-01-08 Thomae Gmbh Dr K Neue phenylessigsaeurederivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3347565A1 (de) * 1983-12-30 1985-07-11 Thomae Gmbh Dr K Neue phenylessigsaeurederivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
ES2179558T3 (es) * 1991-06-21 2003-01-16 Boehringer Ingelheim Pharma Procedimiento para preparar (s)-3-metil-1-(2-piperidino-fenil)-1-butilamina.
EP0589874B1 (de) * 1991-06-21 1999-09-08 Boehringer Ingelheim Pharma KG Verwendung von (s)(+)-2-äthoxy-4-[n-[1-(2-piperidino-phenyl)-3-methyl-1-butyl]aminocarbonylmethyl]-benzoesäure zur herstellung eines langzeitantidiabetikums
FR2763590B1 (fr) * 1997-05-22 2000-03-24 Synthelabo Derives d'acides[[[(arylmethyl)amino]carbonyl] alkyl]- aromatiques, leur preparation et leur application en therapeutique
DE60124861T2 (de) 2000-01-21 2007-05-10 Novartis Ag Zusammensetzungen bestehend aus dipeptidylpeptidase-iv inhibitoren und antidiabetica
WO2004018442A1 (en) * 2002-08-23 2004-03-04 Dr. Reddy's Laboratories Limited Crystalline and amorphous forms of (s) -repaglinide and the processes for preparation thereof
EP1636199A2 (de) * 2003-05-14 2006-03-22 Cilag AG Verfahren zur herstellung von phenylessig derivaten
WO2004103983A1 (en) * 2003-05-26 2004-12-02 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-[n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl]benzoic acid derivatives
PE20050630A1 (es) * 2003-06-09 2005-09-22 Boehringer Ingelheim Int Compuestos heterociclicos como inhibidores del papiloma virus
FR2875805B1 (fr) * 2004-09-27 2006-12-29 Genfit S A Composes derives de n-(benzyl) phenylacetamide substitues, preparation et utilisations
CN1305863C (zh) * 2004-12-27 2007-03-21 浙江大学 (s)－异丙基－(2－哌啶)苯基－甲基胺的合成方法
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
WO2007033266A2 (en) 2005-09-14 2007-03-22 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors for treating diabetis
EP2177221A1 (en) 2008-10-20 2010-04-21 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of substantially optically pure Repaglinide and precursors thereof
AU2010247414B2 (en) 2009-05-15 2013-08-01 Novartis Ag Aryl pyridine as aldosterone synthase inhibitors
ES2430088T3 (es) 2009-05-15 2013-11-18 Novartis Ag Derivados de benzoxazolona como inhibidores de aldosterona sintasa
EP2594557B1 (en) 2009-05-28 2016-08-10 Novartis AG Substituted aminopropionic derivatives as neprilysin inhibitors
MX2011012627A (es) 2009-05-28 2011-12-14 Novartis Ag Derivados aminobutiricos sustituidos como inhibidores de nepralisina.
WO2011041293A1 (en) 2009-09-30 2011-04-07 Takeda Pharmaceutical Company Limited Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors
ES2663351T3 (es) 2009-11-17 2018-04-12 Novartis Ag Derivados de aril-piridina como inhibidores de la aldosterona sintasa
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
EP2507234B1 (en) 2009-11-30 2014-03-12 Novartis AG Imidazole derivatives as aldosterone synthase inhibitors
CN102834393B (zh) 2010-02-03 2015-07-22 武田药品工业株式会社 细胞凋亡信号调节激酶1抑制剂
US8877815B2 (en) 2010-11-16 2014-11-04 Novartis Ag Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
US8673974B2 (en) 2010-11-16 2014-03-18 Novartis Ag Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
WO2012095548A2 (es) 2011-01-13 2012-07-19 Centro De Investigación Biomédica En Red De Enfermedades Neurodegenerativas (Ciberned) Compuestos para el tratamiento de enfermedades neurodegenerativas
UY35144A (es) 2012-11-20 2014-06-30 Novartis Ag Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca
CN105073762B (zh) 2013-02-14 2017-03-08 诺华股份有限公司 作为nep(中性内肽酶)抑制剂的取代的联苯丁酰膦酸衍生物
EP3024845A1 (en) 2013-07-25 2016-06-01 Novartis AG Cyclic polypeptides for the treatment of heart failure
UY35671A (es) 2013-07-25 2015-02-27 Novartis Ag Bioconjugados de polipéptidos de apelina sintética
SG11201704758XA (en) 2015-01-23 2017-08-30 Novartis Ag Synthetic apelin fatty acid conjugates with improved half-life
UY38072A (es) 2018-02-07 2019-10-01 Novartis Ag Compuestos derivados de éster butanoico sustituido con bisfenilo como inhibidores de nep, composiciones y combinaciones de los mismos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3100575A1 (de) * 1981-01-10 1982-09-02 Dr. Karl Thomae Gmbh, 7950 Biberach "neue benzoesaeuren, ihre herstellung und ihre verwendung als arzneimittel"
DE3100535A1 (de) * 1981-01-10 1982-08-12 Dr. Karl Thomae Gmbh, 7950 Biberach "neue carbonsaeure-derivate, ihre herstellung und ihre verwendung als arzneimittel"
EP0099017B1 (de) * 1982-07-06 1988-03-02 Dr. Karl Thomae GmbH Neue Phenylessigsäure-Derivate, ihre Herstellung und diese Verbindungen enthaltende Arzneimittel
FR2554875B1 (fr) * 1983-11-10 1986-02-28 Dba Amplificateur hydraulique de freinage
DE3523466A1 (de) * 1985-07-01 1987-01-08 Thomae Gmbh Dr K Neue phenylessigsaeurederivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3347565A1 (de) * 1983-12-30 1985-07-11 Thomae Gmbh Dr K Neue phenylessigsaeurederivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
LU90301I2 (fr) 1998-12-21
HK87492A (en) 1992-11-13
BG61519B2 (bg) 1997-10-31
PT82832B (pt) 1988-12-15
NL980034I1 (nl) 1999-02-01
DK613184D0 (da) 1984-12-20
IL73963A (en) 1989-01-31
AU577815B2 (en) 1988-10-06
CS409791A3 (en) 1992-07-15
NO162819C (no) 1990-02-21
NO845282L (no) 1985-07-01
NO168302B (no) 1991-10-28
CA1292000C (en) 1991-11-12
ATE44027T1 (de) 1989-06-15
HUT37773A (en) 1986-02-28
NO862532L (no) 1986-12-29
EP0147850B1 (de) 1989-06-14
HU194548B (en) 1988-02-29
SG55492G (en) 1992-10-02
GR82614B (en) 1985-05-02
DK613184A (da) 1985-07-01
ES8802145A1 (es) 1988-04-01
EP0207331A1 (de) 1987-01-07
DE3347565A1 (de) 1985-07-11
NZ210657A (en) 1988-10-28
DK296686A (da) 1986-12-26
AU3721084A (en) 1985-08-01
FI82689B (fi) 1990-12-31
IL79217A0 (en) 1986-09-30
ES8605500A1 (es) 1986-03-16
FI845145L (fi) 1985-07-01
ES545879A0 (es) 1986-02-01
ES545883A0 (es) 1986-02-01
DE3522604A1 (de) 1987-01-08
AU5913986A (en) 1987-01-08
FI80447C (fi) 1990-06-11
EP0207331B1 (de) 1990-05-23
DE19875044I2 (de) 2002-07-18
ES545880A0 (es) 1986-02-01
KR900005320B1 (ko) 1990-07-27
ES8604545A1 (es) 1986-02-01
PT79772A (de) 1985-01-01
ES545882A0 (es) 1986-02-01
ES8604546A1 (es) 1986-02-01
AU583631B2 (en) 1989-05-04
FI82689C (fi) 1991-04-10
PT82832A (de) 1986-07-01
ES556495A0 (es) 1988-04-01
MX9202772A (es) 1992-06-30
JPH0739405B2 (ja) 1995-05-01
NZ216640A (en) 1989-02-24
ES8604547A1 (es) 1986-02-01
ES539078A0 (es) 1986-03-16
IL79217A (en) 1991-01-31
EP0147850A2 (de) 1985-07-10
FI862650A0 (fi) 1986-06-23
JPH0623200B2 (ja) 1994-03-30
IE57700B1 (en) 1993-03-10
NO862532D0 (no) 1986-06-24
PT79772B (de) 1987-01-05
JPS62474A (ja) 1987-01-06
DK167439B1 (da) 1993-11-01
DK167573B1 (da) 1993-11-22
NO1999016I1 (no) 1999-07-20
ES545881A0 (es) 1986-02-01
ZA864695B (en) 1988-02-24
ZA8410103B (en) 1986-09-24
GR861558B (en) 1986-10-17
EP0147850A3 (en) 1985-08-07
CA1225398A (en) 1987-08-11
DE3478682D1 (en) 1989-07-20
FI845145A0 (fi) 1984-12-28
FI862650A (fi) 1986-12-26
FI80447B (fi) 1990-02-28
KR850004590A (ko) 1985-07-25
IE843349L (en) 1985-06-30
NO168302C (no) 1992-02-05
DD231348A5 (de) 1985-12-24
IL73963A0 (en) 1985-03-31
ES8604544A1 (es) 1986-02-01
JPS60158171A (ja) 1985-08-19
NO162819B (no) 1989-11-13
DK296686D0 (da) 1986-06-24

Similar Documents

Publication Publication Date Title
ES8604544A1 (es) Procedimiento para preparar nuevos derivados de acidos feni-laceticos
ATE19513T1 (de) Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
ES2000603A6 (es) Un procedimiento para preparar aril-piperidino carbinoles
IE45700L (en) PYRAZOLO (3,4-b) PYRIDINES
BG104505A (en) Process for the preparation of thiazolidinedione derivatives
PT77878A (de) Cephalosporinderivate und verfahren zu ihrer herstellung
ATE13425T1 (de) Piperidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
PT79118B (de) Cephalosporinderivate und verfahren zur ihrer herstellung
ES2016017A6 (es) Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico.
ES2001953A6 (es) Procedimiento para la obtencion de compuestos de b -lactama.
AU3431399A (en) Process for the preparation of 2-hydroxyalkyl halophenones
HU9701295D0 (en) New process for making intermediers
PL348919A1 (en) Method for preparing bicyclic compounds and use of said method for preparing an interleukin-1$g(b) conversion enzyme (ice) inhibitor
JPS5731673A (en) Piperazine derivative
ATE258545T1 (de) Antioxidantien, verfahren zu ihrer herstellung und ihre verwendungen
IE831445L (en) Process for the production of 1-ethoxycarbonyloxyethyl ester¹of 6-(d-(-)-ó-amino-ó-phenylacetamido) penicillanic acid
FR2290892A1 (fr) Nouveaux composes organiques, leur preparation et leur application comme medicaments
JPS5629585A (en) Preparation of dibenz b,f oxepin derivative
IE45275L (en) 2-[2-(2-amino-4-pyrimidinyl) ethenyl-quinoxaline] - 1,¹4-dioxides

Legal Events

Date Code Title Description
SPCD Supplementary protection certificate rejected

Free format text: REPAGLINIDA (NOVONORM) MOTIVO: ART. 3.2 DEL REGLAMENTO CE 1610/96 DE 23 DE JULIO, SEGUN EL CUAL EL TITULAR DE VARIAS PATENTES REFERIDAS A UN MISMO PRODUCTO NO PODRA OBTENER VARIOS CERTIFICADOS PARA DICHO PRODUCTO Y POR SUBSISTIR DEFECTOS QUE NO HAN SIDO DEBIDAMENTE SUBSANADOS EN EL PLAZO ESTABLECIDO.

Spc suppl protection certif: C9900007

Filing date: 19990216

Effective date: 20020710